Top 10 Life Science VC Funds in Sweden

Last updated: Apr 2024 A list of 10 VC funds that invest in Life science startups based in Sweden. We rank investors based on the number of investments they made in Life science companies from Sweden. We update this investor list every month.

Top 10 Life Science VC Funds in Sweden

Investor	Life Science Sweden investments
Crowberry Capital	3
Inventure	3
Noaber	2
Norrsken VC	2
HealthCap	1
Almi Invest	1
SEB Venture Capital	1
Sofinnova Partners	1
Industrifonden	1
CBC Investment Group	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

Investment focus

Software, Gaming, Health Care
Seed, Series A, Pre-Seed
Iceland, Denmark, Finland

Portfolio highlights

Saidot — Saidot is a governance tool for safe, ethical and transparent AI.
Rocky Road — At Rocky Road, we are redefining social gaming with our social gaming network. We are hiring!
Scaleup Finance — Improve your financial management

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Investment focus

Software, Information Technology, Mobile
Seed, Series A, Series B
Finland, Sweden, Denmark

Portfolio highlights

Leya AI — Feel and sound like an English native in 3 months
UltiHash — Data powers breakthroughs. UltiHash is the storage foundation to accelerate them: blazing fast, highly efficient, and built for sustainable long-term growth.
Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Investment focus

Health Care, Medical, Fitness
Seed, Series A, Funding Round
The Netherlands, Israel, Sweden

Portfolio highlights

Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Alba Health — Discover your baby's gut health & microbiome for the best start in life.

We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.

Investment focus

Software, Health Care, Food and Beverage
Seed, Series A, Funding Round
Sweden, United Kingdom, Germany

Portfolio highlights

Cellcolabs — Cellcolabs provides high quality stem cells at competitive prices for use within research and treatments.
Fever — Grid balancing to enable more re-newables
Heart Aerospace — Heart’s mission is to create the fastest, most affordable and sustainable transportation for regional travel to every corner of the world. Their first aircraft is the ES-19, a nineteen-passenger airliner with an operating range of 400 km. Heart's goal is to have the aircraft certified for commercial operation by 2026.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Vicore Pharma — Vicore Pharma is a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders. It develops drugs that act through the AT2 receptor. The company’s drug candidate C21 aims to improve the treatment of idiopathic pulmonary fibrosis, a rare disease for which C21 has been granted orphan drug designation both in the EUand the US. In addition, C21 is explored pre-clinically in a number of rare diseases where the AT2 receptor plays an important role. The company is based in Astra Zeneca’s Bioventurehub in Mölndal.
Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.

ALMI Invest is a venture capital company which invests in Swedish companies with exciting, scalable business models and motivated entrepreneurs. ALMI Invest consists of eight regionally based venture capital funds, all with local offices and experienced local investment managers. We manage a total of SEK 1 billion. Unlike most venture capitalists,we can invest in a wide range of businesses. A strong team of entrepreneurs, a scalable business model and an initial revenue stream are more important than the line of business when we invest.Our first, initial investment would typically be SEK 2-4 million. During the lifetime of an investment, sums of up to SEK 10 million can be ventured. We always syndicate with an investment partner (another venture capitalist or angel investor) from Sweden or otherwise which means that we can take a maximum of 50 percent of an investment round.ALMI Invest was founded in 2009 by ALMI Fretagspartner together with regional investors. Half of our capital comes from European Union structural funds, which accounts for an investment of SEK 500 million. The other 50 per cent comes from regional investors and ALMI Fretagspartner.

Investment focus

Software, Health Care, Information Technology
Funding Round, Seed, Pre-Seed
Sweden, United States, United Kingdom

Portfolio highlights

Dicot — Dicot is a pharmaceutical company focused on drug discovery and the development of novel lifestyle drugs to enrich patients' lives. The Company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in the pre-clinical stage of development.
Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Nordic Forestry Automation — The forestry sector is standing before unprecedented challenges in adapting to increased demand for sustainable raw materials, carbon storage, biodiversity conservation and a shortage of highly skilled machine operators. Digital tools, precision forestry and automation will play a crucial role in

SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.

Investment focus

Software, Information Technology, Financial Services
Funding Round, Series A, Series B
Sweden, Denmark, United Kingdom

Portfolio highlights

Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Cure51 — Cure51 mission is to create a database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

Investment focus

Software, Biotechnology, Information Technology
Funding Round, Series A, Seed
Sweden, United States, Denmark

Portfolio highlights

Arevo — Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment.
AlixLabs — AlixLabs is an innovative startup enabling the semiconductor industry to scale down in a cost effective manner
Texray AB — REDUCE YOUR RADIATION EXPOSURE WITH TEXRAY REDUCE YOUR RADIATION EXPOSURE WITH TEXRAY THE HEART AND SOUL OF TEXRAY Texray has developed the first radiation protection textile in the world, to address the need for improved

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.